Patent · US Active

Modulators of ROR1-ROR2 binding

US10913798B2 · kind B2 · utility

1Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 25, 2016
Grant dateFeb 9, 2021
Priority date
Expiry dateSep 30, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/02
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided herein are, inter alia, methods of identifying agents that are capable inhibiting the binding (e.g., coupling) between a ROR1 protein and a ROR2 protein. By interfering with ROR1-ROR2 coupling (binding) the agents identified using the methods provided herein inhibit non-canonical Wnt5a signaling. Thus, the agents identified by the methods provided herein may, inter alia, be useful for cancer diagnosis and therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.